Cancer Research

 
Stock Quotes for Cancer Research top ^
  • Industry: Health Information Services
  • Sector: Technology
  • Stock Type: Distressed
Sign-up for cthz investment picks

 
News Articles for Cancer Research top ^
Regis Corp.
Sign-up for Regis Chair for Breast Cancer Research Established investment picks
Company expands lung cancer clinical program for its Precision Cancer MonitoringSM solution to up to 700 patients at three leading cancer centers SAN DIEGO , Jan.
Sign-up for Trovagene Collaborates with UC San Diego Moores Cancer Center to Demonstrate Clinical Utility of Detecting and Monitoring EGFR Mutations in Lung Cancer Patients investment picks
2014/10/30
FORT WAYNE, Ind., Oct.
Sign-up for Photo Release -- Vera Bradley Foundation for Breast Cancer Raises $3.2 Million This Year investment picks
2014/11/13
While it may not be surprising that breast and lung cancers are top of mind when people hear the word “cancer,” 60% of respondents to a recent six-country survey about cancer awareness know almost nothing about pancreatic cancer, a leading cancer killer.
Sign-up for Global Survey Finds That Pancreatic Cancer, a Leading Cause of Cancer Deaths, is Virtually Unknown by Many in Europe and US investment picks
The International Breast Cancer Study Group (IBCSG), Breast International Group (BIG), and Merck, known as MSD outside the United States and Canada, today announced the opening of the PANACEA study, a global collaborative study exploring a new way to treat HER2+ breast cancer that has become resistant to the current standard of care.
Sign-up for International Breast Cancer Study Group, Breast International Group and Merck Announce Opening of International PANACEA Study of Patients with HER2+ Breast Cancer investment picks
Myriad myRisk™ Hereditary Cancer Test Finds 105 Percent More Mutations Myriad myChoice ™ HRD Predicted Platinum Response in Early TNBC BRAC Analysis ® Predicted Platinum Response in Metastatic TNBC SALT LAKE CITY, Dec.
Sign-up for Three New Myriad Studies Highlighted at 2014 San Antonio Breast Cancer Symposium investment picks
2014/11/20
As the holidays approach, most of us are conjuring up images of a perfectly roasted turkey with all the fixings, followed by a luscious pumpkin pie and perhaps an overfull stomach.
Sign-up for Chef Michael Ferraro, the Pancreatic Cancer Action Network and Meals to Heal Team up with Celgene to Address Nutritional Needs and Challenges Faced by Pancreatic Cancer Patients and Caregivers investment picks
2014/12/2
A new survey reveals that 77 percent of working women with breast cancer, including those with metastatic disease, feel that working aids in their recovery – a view shared almost unanimously by healthcare professionals, who were also surveyed (92%). The Supporting Workplace Conversations survey is the first to comprehensively examine the perspectives of working women with breast cancer, healthcare professionals and employers on the topic of breast cancer and the workplace.
Sign-up for New Survey Finds Majority of Women with Breast Cancer Who Work Want to Do So Even While Undergoing Treatment investment picks
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that a paper, titled “PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells,” has been published in Cancer Research , a peer-reviewed journal of the American Association for Cancer Research (AACR). The paper discusses results from preclinical research evaluating VS-5584, a highly potent, selective small molecule inhibitor of mTORC1/2 and Class I PI3K kinases, which preferentially targets cancer stem cells (CSCs) in vitro and in vivo .
Sign-up for Verastem Announces Publication of Scientific Data for VS-5584 in Cancer Research investment picks
> Issuance of patent 8,865,882 covers four probe set used in CGI's proprietary FISH-based HPV-Associated Cancer Test (FHACT®) > FHACT® cervical cancer detection test has potential application for more than 2 million patients per year in the United States RUTHERFORD, N.J., Oct.
Sign-up for Cancer Genetics Inc. Granted Patent for Genomic Probe Set Used in Proprietary Test for Cervical and Other HPV-Associated Cancers investment picks
Exelixis, Inc. (NASDAQ:EXEL) today announced positive top-line results from a randomized phase 2 trial of cabozantinib and erlotinib alone or in combination as second- or third-line therapy in patients with stage IV EGFR wild-type non-small cell lung cancer (NSCLC). This trial (Study E1512) is sponsored by the U.S. National Cancer Institute (NCI) through a Cooperative Research and Development Agreement between the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis, NCI and Exelixis.
Sign-up for Exelixis Announces Positive Top-Line Results From a Phase 2 Trial of Cabozantinib and Erlotinib in Patients With EGFR Wild-Type Non-Small Cell Lung Cancer investment picks
CVS/pharmacy to host in-store fundraising campaign during November's Lung Cancer Awareness Month to support Stand Up To Cancer WOONSOCKET, R.I. , Nov.
Sign-up for CVS Health Announces $10 Million Commitment to Stand Up To Cancer to Fund Innovative Cancer Research investment picks
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that multiple posters for the Prosigna ® Breast Cancer Gene Signature Assay based on PAM50 will be presented at the 37 th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). These include a prospective study of the Prosigna Assay on adjuvant clinical decision-making in women with Estrogen Receptor-Positive (ER+), HER2-negative, node-negative breast cancer.
Sign-up for NanoString Technologies Announces Prosigna Presentations at the 2014 CTRC-AACR San Antonio Breast Cancer Symposium investment picks
2014/12/15
The University of Texas MD Anderson Cancer Center and UnitedHealthcare have launched a pilot to explore a new cancer care payment model for head and neck cancers that focuses on quality patient care and outcomes.
Sign-up for MD Anderson, UnitedHealthcare Launch New Cancer Care Payment Model investment picks
http://media.marketwire.com/attachments/201112/37556_Genetic_Technologies_logo95.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1165552&ProfileId=051205&sourceType=1 MELBOURNE, AUSTRALIA --
Sign-up for Clinical Validation Study Supporting the Use of BREVAGenplus(R) in Breast Cancer Risk Assessment investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Cancer Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Canadian World Fund  |  Next: Cancer Research Center